Skip to main content
Premium Trial:

Request an Annual Quote

Tute Raises $3.9M in Venture Capital

NEW YORK (GenomeWeb) – Utah-based bioinformatics company Tute Genomics said today it closed a second Series A1 round of venture capital funding in which it raised over $3.9 million.

A company representative told GenomeWeb that Tute will use the funds to scale up its commercialization efforts including expanding its sales and marketing, and engineering teams. It has set aside funds from the new capital to hire a vice president of sales, a vice president of marketing, and a chief scientific officer.

The list of investors in this series include Intermountain Healthcare, a network of 22 hospitals and 185 physician clinics; Healthbox, a company that supports innovation and entrepreneurship in healthcare; and Tencent, a provider of internet services in China. As part of the investment, Nina Nashif, founder and CEO of Healthbox, will join Tute's board.

Last December, Tute raised $2.3 million in a Series A1 funding round led by UK-based Eurovestech with participation from Peak Ventures and other unnamed angel investors. 

More recently, the company signed an agreement with PrimeBio to provide whole-exome and targeted gene panel interpretation services. It also joined forces with DNAnexus to provide an integrated solution for genomic data management, analysis, and interpretation. The company also teamed up with Google and researchers at theUniversityofTexasto make its database of 8.5 billion genetic variant annotations publicly available through the Google Genomics infrastructure.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.